From the world’s first human genome to our 650,000th, we’ve been delivering quality at scale for more than 30 years.
Broad Clinical Labs (BCL), a CLIA licensed and CAP accredited wholly owned subsidiary of the Broad Institute, offers services to power your multi-omic data generation and analysis needs, across a range of research, translational, and clinical Dx applications.
BCL develops and offers impactful services to the world, powers transformative projects, and drives adoption of the latest technologies and novel molecular assays. As a non-profit backed by 30+ years of expertise and partnership with thought leaders in the Broad community and beyond, you can trust us to deliver dependable, advanced multi-omic services at competitive prices.
Blended Genome Exome (BGE) is a qualitative assay that combines low pass genome and deeper exome sequencing of single nucleotide variants (SNVs) and small insertions and deletions (InDels) in human genome DNA extracted from saliva and blood samples. BGE is ideal for large scale germline gene-disease discovery studies where the low pass genome region is used as an unbiased alternative to microarray genotyping in GWAS applications and the clinical depth exome is used for gene panels for monogenic conditions.
Access whole genome sequencing services backed by 30 years of field-leading experience in providing high-quality, reliable data at scale. With a variety of modalities, outputs, and add-ons, our WGS services offer end-to-end solutions, from research to clinical diagnostic applications, to meet your needs.
Sequencing of Customer-Prepared Libraries (Walk-Up Sequencing)
Need rapid turnaround sequencing for your pre-constructed libraries and library pools? Our convenient Walk-Up Sequencing (WUS) service provides access to the latest sequencing technologies – including the Illumina® NovaSeq X Plus, PacBio Revio™, and Ultima Genomics UG 100™ – operated by expert staff, whether you “walk up” to drop libraries off in person or ship them to our facility.